Release Date: 31/03/10 12:12 Summary: Funding Support received from Private Investor Price Sensitive: Yes Download Document 113.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%